Results 311 to 320 of about 5,263,232 (399)
Patterns of recurrence in bladder cancer treated by irradiation and/or cystectomy
M.A. Batata +5 more
openalex +1 more source
Abstract Background CD163 is a scavenger receptor predominantly expressed on the surfaces of macrophages in various mammalian species and is a marker of anti‐inflammatory (M2‐like) macrophages. High density of CD163‐positive tumor‐associated macrophages (TAMs) is associated with worse prognosis in various patient tumors.
Yoichi Saito +9 more
wiley +1 more source
Extracellular Vesicle‐Based mRNA Therapeutics and Vaccines
This review provides a comprehensive analysis of recent advancements in extracellular vesicle (EV)‐based messenger RNA (mRNA) applications for therapeutics and vaccines. It systematically outlines strategies for mRNA encapsulation within EVs and elucidates the challenges associated with this technology, offering insights into future research directions
Qi Li +6 more
wiley +1 more source
Artificial sweeteners and bladder cancer in Manchester, U.K., and Nagoya, Japan
Alan S. Morrison +5 more
openalex +1 more source
The role of spectral characteristics of urine in bladder cancer diagnostics. [PDF]
Velísková M +6 more
europepmc +1 more source
Multi‐Energy Integrated Photocatalysis for Antitumor Therapy
This comprehensive review summarizes recent advancements in piezo‐photocatalysts and photothermal‐photocatalysts for cancer therapy. It begins by outlining the principles of piezo‐photocatalysis and photothermal‐photocatalysis, followed by a discussion of various multi‐energy integrated photocatalysts designed for single‐, dual‐, triple‐, and tetra ...
Li Zhang +4 more
wiley +1 more source
The miRNA-immune axis in bladder cancer: systematic evidence for a new era of immunotherapy precision. [PDF]
Dulf DV +10 more
europepmc +1 more source
Schematic overview illustrating the anticancer mechanisms of selected natural products (resveratrol, quercetin, berberine) targeting EGFR and HER2 signaling pathways in tumor cells. These compounds inhibit receptor activation and downstream oncogenic cascades, including PI3K/Akt/mTOR, MAPK/ERK, and STAT3 pathways.
Iman Ramli +8 more
wiley +1 more source

